GPT and chronic kidney disease: Compared with baseline levels, the AST level, the ALT abnormal rate and the HBV DNA positive rate were significantly reduced in CHB patients after 96-week of TAF treatment, while no significant abnormalities were seen in lipids and CKD grading (Table 5).